Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,782,069
+$11,938,218 QoQ
Shares Held
600,834
+83.7% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 247 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. TNGX ranks #89 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TNGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,782,069 | 600,834 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,843,851 | 327,144 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,235,627 | 478,062 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,305,752 | 155,447 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $241,380 | 47,145 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $481,538 | 351,489 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $841,198 | 272,233 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,350,340 | 175,369 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $702,701 | 81,900 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $857,861 | 108,043 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $591,979 | 59,796 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $585,022 | 51,956 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $215,915 | 65,035 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $394,079 | 99,767 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,068,505 | 147,380 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $348,091 | 96,158 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $364,410 | 80,444 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $605,649 | 79,901 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,027,024 | 93,878 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $387 | 30 | Shares | Defined | 2021-11-15 | |
| 2020-09-30 BCTG | — | 832 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||